PerkinElmer Life and Analytical Sciences, Wallac, OY
FDA record creation date
Apr 27, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II
Reason stated in the source
hCG analyte concentrations may be decreased up to 15- 20% at the lower measuring range of hCG concentrations.
Source facts
Action
Perkin Elmer initiated notification on January 10, 2018. The Recall Letter delivered to the end customer by email facilitated through the PerkinElmer Technical Support Group. PerkinElmer requires customers to:
Inspect DELFIA / AutoDELFIA hCG kit inventory for the affected lots.
Review your QC follow-up of the AutoDELFIA hCG assay for potential decrease in the control concentrations.
If the control values are within your established acceptance range it is safe to report the results
To avoid unnecessary repeat testing of samples, if the control values are out of the acceptance range discontinue use of the DELFIA / AutoDELFIA hCG kit lot and dispose the remaining kits of the lot.
Complete the Response Form with the quantity of affected DELFIA / AutoDELFIA hCG kits you have disposed from your inventory
Initiated
2019-01-10
Root cause
Nonconforming Material/Component
Distribution
Worldwide distribution - US Nationwide distribution. and countries of Austria, Bolivia, UK, Switzerland,Thailand, Finland.
Recall number
Z-1237-2019
Recall status
Open, Classified
CDRH record ID
170822
FDA record created
2019-04-27
Recall event number
82064
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.